Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
August 30, 2003
Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression
Xian-Cheng Jiang, Thomas P Beyer, Zhiqiang Li, et al.
The Journal of Biological Chemistry
|
January 16, 2008
Identification and characterization of a major liver lysophosphatidylcholine acyltransferase
Yang Zhao, Yan-Qun Chen, Tabetha M Bonacci, et al.
The Journal of Clinical Investigation
|
January 1, 1994
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats
L J Black, M Sato, E R Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1997
Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator
R F Kauffman, W R Bensch, R E Roudebush, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents
H S Lin, A A Rampersaud, R A Archer, et al.
The Journal of Biological Chemistry
|
August 15, 2002
Phospholipid transfer protein is regulated by liver X receptors in vivo
Guoqing Cao, Thomas P Beyer, Xiao Ping Yang, et al.
Endocrinology
|
October 28, 2006
Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes
Yanfang Liu, M Dodson Michael, Shera Kash, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2004
Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo
Thomas P Beyer, Robert J Schmidt, Patricia Foxworthy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 1999
Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters
W R Bensch, R A Gadski, J S Bean, et al.
Journal of Lipid Research
|
April 24, 2007
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Yue-Wei Qian, Robert J Schmidt, Youyan Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
August 30, 2003
Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression
Xian-Cheng Jiang, Thomas P Beyer, Zhiqiang Li, et al.
The Journal of Biological Chemistry
|
January 16, 2008
Identification and characterization of a major liver lysophosphatidylcholine acyltransferase
Yang Zhao, Yan-Qun Chen, Tabetha M Bonacci, et al.
The Journal of Clinical Investigation
|
January 1, 1994
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats
L J Black, M Sato, E R Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1997
Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator
R F Kauffman, W R Bensch, R E Roudebush, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents
H S Lin, A A Rampersaud, R A Archer, et al.
The Journal of Biological Chemistry
|
August 15, 2002
Phospholipid transfer protein is regulated by liver X receptors in vivo
Guoqing Cao, Thomas P Beyer, Xiao Ping Yang, et al.
Endocrinology
|
October 28, 2006
Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes
Yanfang Liu, M Dodson Michael, Shera Kash, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2004
Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo
Thomas P Beyer, Robert J Schmidt, Patricia Foxworthy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 23, 1999
Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters
W R Bensch, R A Gadski, J S Bean, et al.
Journal of Lipid Research
|
April 24, 2007
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Yue-Wei Qian, Robert J Schmidt, Youyan Zhang, et al.
Page
of 3